PharmaSGP Holding SE - Asset Resilience Ratio
PharmaSGP Holding SE (PSG) has an Asset Resilience Ratio of 1.11% as of September 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read PharmaSGP Holding SE total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2022)
This chart shows how PharmaSGP Holding SE's Asset Resilience Ratio has changed over time. See PSG total equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down PharmaSGP Holding SE's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of PharmaSGP Holding SE.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €1.45 Million | 1.11% |
| Total Liquid Assets | €1.45 Million | 1.11% |
Asset Resilience Insights
- Limited Liquidity: PharmaSGP Holding SE maintains only 1.11% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
PharmaSGP Holding SE Industry Peers by Asset Resilience Ratio
Compare PharmaSGP Holding SE's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
| No industry peers found with asset resilience data. | ||
Annual Asset Resilience Ratio for PharmaSGP Holding SE (2014–2022)
The table below shows the annual Asset Resilience Ratio data for PharmaSGP Holding SE.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-12-31 | 0.96% | €1.24 Million ≈ $1.45 Million |
€129.11 Million ≈ $150.94 Million |
+0.57pp |
| 2017-12-31 | 0.39% | €327.00K ≈ $382.30K |
€83.40 Million ≈ $97.51 Million |
-0.02pp |
| 2016-12-31 | 0.41% | €328.00K ≈ $383.47K |
€80.00 Million ≈ $93.53 Million |
-4.74pp |
| 2015-12-31 | 5.15% | €3.98 Million ≈ $4.65 Million |
€77.24 Million ≈ $90.31 Million |
-1.05pp |
| 2014-12-31 | 6.21% | €4.25 Million ≈ $4.96 Million |
€68.39 Million ≈ $79.96 Million |
-- |
About PharmaSGP Holding SE
PharmaSGP Holding SE manufactures and sells over-the-counter drugs and other healthcare products in Germany. The company's pharmaceutical products include Baldriparan for the treatment of sleep disorders; Spalt, Formigran, and Kamol massage creams for the treatment of various pain conditions; RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil … Read more